This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory, Hitgen, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3 
1 out of 10 Years Active: 2026
Title: Jiansong Wang: Innovator in Pharmaceutical Compounds
Introduction
Jiansong Wang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic potential. His work is characterized by a focus on innovative solutions to complex medical challenges.
Latest Patents
Wang holds a patent for a class of compounds known as 6,7-dimethoxy-3-(pyridin-2-yl)quinoline. This patent is aimed at inhibiting RET, a receptor tyrosine kinase involved in various cancers. The disclosed compounds are represented by formula (II), along with their isomers or pharmaceutically acceptable salts.
Career Highlights
Jiansong Wang is affiliated with Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., specifically working at the Baiyunshan Pharmaceutical General Factory. His role in this esteemed organization has allowed him to contribute to the advancement of pharmaceutical research and development.
Collaborations
Wang collaborates with talented colleagues, including Jikui Sun and Shuhui Chen. Their combined expertise enhances the innovative capacity of their projects and contributes to the success of their research endeavors.
Conclusion
Jiansong Wang's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of new compounds, highlight the importance of research in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile